From overlooking CMS billing exposure to underestimating CHOW timelines, these errors can derail your acquisition or destroy post-close value.
Find Vetted Home Health Agency DealsHome health agency acquisitions offer strong upside in a growing, recession-resistant market, but regulatory complexity, reimbursement exposure, and licensing hurdles create unique risks. Buyers who skip healthcare-specific diligence routinely overpay or inherit liabilities that erode returns.
Market Size
Approximately $113 billion in the U.S. as of 2023, projected to exceed $170 billion by 2030
Growth Trend
Growing
Recession Resistant
Yes
Market Structure
Highly fragmented
Medicare billing errors, upcoded claims, and RAC audit exposure don't disappear at closing. Buyers who rely solely on seller-provided financials inherit undisclosed overpayment liabilities that CMS can claw back years later.
How to avoid: Commission an independent billing compliance audit covering at least 3 years of claims, denial rates, and overpayment history before signing a letter of intent.
CMS Change of Ownership approval and Medicare re-enrollment can take 90–180 days. Buyers who fail to plan for this gap risk cash flow disruptions and patient census loss immediately after closing.
How to avoid: Engage a healthcare M&A attorney before LOI to model CHOW timelines and structure deal terms with holdbacks tied to successful payor re-enrollment milestones.
Agencies with 80%+ Medicare revenue are highly vulnerable to PDGM reimbursement cuts. Buyers who don't analyze payor diversification may acquire an agency with structurally compressed margins.
How to avoid: Request a detailed payor mix report segmented by Medicare, Medicaid, managed care, and private pay. Flag any single payor exceeding 70% of total revenue.
Skilled nurses and therapists are the agency's core productive assets. High turnover or uncredentialed staff discovered post-close can trigger CMS survey deficiencies and immediate patient census decline.
How to avoid: Verify credentials for all clinical staff, review turnover rates for the prior 24 months, and negotiate key employee retention agreements as a closing condition.
Declining star ratings signal deteriorating clinical quality and reduce competitiveness for value-based care contracts. Buyers often miss this leading indicator by focusing only on historical revenue.
How to avoid: Pull the agency's Care Compare profile and review star rating trends over 3 years. Falling scores warrant a deeper clinical operations review before proceeding.
Many home health agencies rely on a single physician group or hospital system for 50%+ of admissions. If that relationship is owner-driven, it may not survive an ownership transition.
How to avoid: Map all referral sources by volume and determine whether relationships are institutional or personal to the seller. Include referral retention representations in the purchase agreement.
Buyers submit SBA loan applications before independently verifying the Home Health Agency's normalized EBITDA. When diligence reveals add-backs that don't hold, the deal's debt service coverage collapses and the loan fails underwriting.
How to avoid: Build your EBITDA model with conservative add-back assumptions before engaging an SBA lender. At current rates, a $1M SBA 7(a) loan costs approximately $13,000/month — the Home Health Agency needs $195,000+ in post-salary EBITDA to clear 1.25x DSCR.
Buyers close on a Home Health Agency assuming operations transfer smoothly, then discover undocumented processes, informal vendor relationships, and staff who rely on institutional knowledge the seller carries in their head.
How to avoid: Require a 60-day operational documentation period before closing. Walk through every key process with the seller present, document staff responsibilities, vendor contacts, and customer communication protocols. Build a 90-day integration plan before the wire hits.
What experienced buyers verify before committing to a Home Health Agency acquisition.
The specific concerns and miscalculations buyers face in this industry.
Common miscalculations sellers make that reduce their final price or derail a deal.
Typically 90–180 days depending on state and CMS workload. Buyers should structure closings with holdbacks tied to successful Medicare re-enrollment to protect against revenue gaps during this period.
Yes. Home health agencies are SBA-eligible. A common structure includes SBA 7(a) financing, a 10–15% seller note, and a 10% buyer equity injection, with terms tied to clean licensure transfer.
Healthy lower middle market agencies typically show 10–20% EBITDA margins. Margins below 8% may signal billing inefficiencies, excessive owner compensation, or unsustainable labor costs worth investigating.
Most deals in the $1M–$5M revenue range close at 3.5x–6x EBITDA. Agencies with strong star ratings, diversified payor mix, and clean compliance history command the higher end of that range.
More Home Health Agency Guides
DealFlow OS helps you find and evaluate acquisitions with seller signals and due diligence tools. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers